We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.
Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
RANDOX LABORATORIES

Novel Method Prevents Rejection of Transplanted Organs

By BiotechDaily International staff writers
Posted on 28 Jan 2019
Print article
Image: A scanning electron micrograph (SEM) of engineered T-cells lacking coronin 1 (Photo courtesy of the University of Basel).
Image: A scanning electron micrograph (SEM) of engineered T-cells lacking coronin 1 (Photo courtesy of the University of Basel).
A team of Swiss researchers reported finding a method that prevents rejection of transplanted organs without lessening the immune system's ability to fight off infection by pathogenic microorganisms.

The ability of the immune system to discriminate self from non-self is essential for eradicating microbial pathogens but is also responsible for rejection of transplants from a foreign donor. It is not known whether it is possible to selectively suppress this type of immune system rejection while maintaining a functional anti-pathogen defense.

In this regard, investigators at the University of Basel (Switzerland) have been looking for ways to prevent rejection while maintaining a potent antimicrobial defense system.

They reported in the January 15, 2019, online edition of the journal Immunity that mice deficient in the protein coronin 1, a regulator of naive T-cell homeostasis, fully retained foreign donor transplants while maintaining T-cell-specific responses against microbial pathogens. Coronin 1 is a member of the evolutionarily conserved coronin protein family, members of which are widely expressed across the eukaryotic kingdom. Mammals express seven coronin molecules, numbered from coronin 1 to 7. The different coronin proteins have a distinct tissue expression and have been reported to be involved in a wide array of cellular functions including calcium homeostasis, cytoskeletal dynamics, immune and inflammatory responses, neuromuscular transmission as well as cognition and behavior.

Mechanistically, coronin 1-deficiency was found to increase cyclic adenosine monophosphate (cAMP) concentrations to suppress these specific T-cell responses. Thus, elevated cAMP prevented rejection of foreign donor transplants. Furthermore, a prior transfer of coronin 1-deficient T-cells was sufficient to induce the anti-rejection response.

To maintain the immune system's antimicrobial defense, the investigators used co-stimulation on microbe-infected antigen presenting cells to overcome the cAMP-mediated immunosuppression and maintain anti-pathogen immunity.

"By removing coronin 1, we observed that the T-cells not only massively suppressed the immune response to the transplanted organ but even actively prevented its rejection," said first author Dr. Rajesh Jayachandran, a visiting scientist at the University of Basel. "At the same time, we were astonished that coronin 1-depleted T-cells continue to fight infections."

Related Links:
University of Basel


Print article

Channels

Business

view channel

Collaborative Agreement to Aid in Setting Guidelines for Evaluating Potential Ebola Therapy

Cooperation between an Israeli biopharmaceutical company and medical branches of the US government is designed to set ground rules for continued evaluation of an experimental therapy for Ebola virus disease. RedHill Biopharma Ltd. (Tel Aviv, Israel), a biopharmaceutical company primarily focused on development and c... Read more
Copyright © 2000-2019 Globetech Media. All rights reserved.